Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Iradimed (IRMD) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Iradimed (IRMD) over the last 12 years, with Q3 2025 value amounting to 0.73.

  • Iradimed's Asset Utilization Ratio fell 596.46% to 0.73 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.73, marking a year-over-year decrease of 596.46%. This contributed to the annual value of 0.77 for FY2024, which is 419.98% up from last year.
  • According to the latest figures from Q3 2025, Iradimed's Asset Utilization Ratio is 0.73, which was down 596.46% from 0.75 recorded in Q2 2025.
  • In the past 5 years, Iradimed's Asset Utilization Ratio ranged from a high of 0.78 in Q2 2024 and a low of 0.45 during Q1 2021
  • In the last 5 years, Iradimed's Asset Utilization Ratio had a median value of 0.73 in 2025 and averaged 0.67.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first plummeted by 2149.48% in 2021, then skyrocketed by 3520.53% in 2022.
  • Iradimed's Asset Utilization Ratio (Quarter) stood at 0.52 in 2021, then rose by 24.56% to 0.65 in 2022, then increased by 13.06% to 0.73 in 2023, then increased by 4.17% to 0.76 in 2024, then fell by 4.29% to 0.73 in 2025.
  • Its Asset Utilization Ratio was 0.73 in Q3 2025, compared to 0.75 in Q2 2025 and 0.75 in Q1 2025.